fda drug safety communication semaglutide naion 2025 You've seen the headlines. Should you be worried about medications, like Ozempic, leading to vision loss? Read the full story on Today Show https://ow.ly/zeEX50WBHhz Semaglutide just got FDA-approved for

Semaglutide can cause some side effects, especially when you first start taking it or when your dose is increased

Key cardiovascular and metabolic conditions include: Hypertension particularly nocturnal hypotension or poorly controlled blood pressure Diabetes mellitus both type 1 and type 2, with microvascular complications Hyperlipidemia contributing to atherosclerotic vascular disease Obstructive sleep apnea causing intermittent hypoxia and hemodynamic fluctuations Coronary artery disease reflecting systemic atherosclerosis Smoking promoting endothelial dysfunction and vascular disease Age represents an independent risk factor, with NAION incidence increasing significantly after 50 years

Chen, W., Cai, P., Zou, W

10.1007/s00125-005-1717-3 12 CunninghamS